Results 81 to 90 of about 146,093 (222)

The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms

open access: yesClinical Hypertension, 2020
There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection.
Craig Steven McLachlan
doaj   +1 more source

Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations

open access: yesResearch Reports in Clinical Cardiology, 2013
Jocelyn D Jones,1 Sylvia H Jackson,1 Charlie Colquitt21College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Jacksonville, FL, USA; 2College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tampa, FL ...
Jones JD, Jackson SH, Colquitt C
doaj  

Preclinical and clinical profile of valsartan, a selective angiotensin II type-1 receptor blocker.

open access: yesFolia Pharmacologica Japonica, 2002
Valsartan (Diovan) is a potent, orally active, specific, and highly selective blocker for the AT1-receptor subtype. The antihypertensive effects of oral treatment with valsartan were preclinically demonstrated in the sodium-depleted marmosets, renal hypertensive rats (2K1C), spontaneous hypertensive rats (SHR) and stroke-prone SHR.
Masaaki, Kimura   +2 more
openaire   +3 more sources

Pharmacological and clinical profile of telmisartan, a selective angiotensin II type-1 receptor blocker

open access: yesFolia Pharmacologica Japonica, 2004
Telmisartan (Micardis) is a potent, long-lasting, nonpeptide angiotensin II type-1 (AT(1)) receptor blocker (ARB) that is indicated for the treatment of essential hypertension. In receptor binding studies, telmisartan showed a high affinity and selectivity for the human AT(1) receptors compared with AT(2) receptors and a slower dissociation rate from ...
Motohiko, Chachin   +4 more
openaire   +3 more sources

Renovascular and renoprotective properties of telmisartan: clinical utility

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2010
Marco Ladino, Ivonne Hernandez SchulmanNephrology-Hypertension Section, Veterans Affairs Medical Center and Division of Nephrology and Hypertension and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL ...
Marco Ladino, Ivonne Hernandez Schulman
doaj  

Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling

open access: yesFEBS Open Bio, 2014
Staphylococcal nuclease domain containing-1 (SND1) is overexpressed in human hepatocellular carcinoma (HCC) patients and promotes tumorigenesis by human HCC cells.
Prasanna K. Santhekadur   +9 more
doaj   +1 more source

Effect of systemic administration of valsartan, an angiotensin II type 1 receptor blocker, on retinal circulation in healthy humans [PDF]

open access: bronze, 2008
Taiji Nagaoka   +5 more
openalex   +1 more source

The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers [PDF]

open access: hybrid, 2019
Michio Fukuda   +9 more
openalex   +1 more source

P2289Interaction of statin therapy to angiotensin ii receptor type 1 blockers in erectile dysfunction patients. effect on endothelial function and aortic stiffness [PDF]

open access: bronze, 2018
N. Ioakeimidis   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy